ViaCyte's Series C - II Round

ViaCyte raised a round of funding on July 10, 2013.

ViaCyte, a private company that has emerged as a provider in the field of regenerative medicine, is focused on developing a novel therapy for the treatment of diabetes. The Company's lead product is b…

Articles about ViaCyte's Series C - II Round: